KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Stereotaxis (STXS) EBIAT (2016 - 2025)

Stereotaxis (STXS) has disclosed EBIAT for 16 consecutive years, with -$5.5 million as the latest value for Q4 2025.

  • Quarterly EBIAT rose 26.4% to -$5.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$21.6 million through Dec 2025, up 9.99% year-over-year, with the annual reading at -$21.6 million for FY2025, 9.99% up from the prior year.
  • EBIAT for Q4 2025 was -$5.5 million at Stereotaxis, up from -$6.5 million in the prior quarter.
  • The five-year high for EBIAT was -$1.2 million in Q2 2021, with the low at -$7.5 million in Q4 2024.
  • Average EBIAT over 5 years is -$4.8 million, with a median of -$5.0 million recorded in 2023.
  • The sharpest move saw EBIAT surged 36.96% in 2021, then plummeted 323.95% in 2022.
  • Over 5 years, EBIAT stood at -$3.4 million in 2021, then decreased by 23.82% to -$4.2 million in 2022, then dropped by 21.33% to -$5.0 million in 2023, then plummeted by 49.11% to -$7.5 million in 2024, then rose by 26.4% to -$5.5 million in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at -$5.5 million, -$6.5 million, and -$3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.